Prosensa Holding BV (RNA)

[oldberkeley]

It's certainly good news for us stockholders! But keep in mind that they're talking about clinical significance as opposed to statistical significance: the relative importance of the two is a topic of frequent debate.

I'm still maintaining my humble opinion that the stock's not going either to the moon or to the dumps, but instead a gradual climb upwards to a more realistic valuation.